Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development

Journal of Women's Health and Gender-Based Medicine

Volumn 10, Issue 5, 2001, Pages 441-449

  Coker, A L ^a   Sanders, L C ^a   Bond, S M ^b   Gerasimova, T ^c   Pirisi, L ^c  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; VIRUS DNA;

ADOLESCENT; ADULT; AGE; ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DEVICE; DNA DETERMINATION; FAMILY PLANNING; FEMALE; HORMONAL CONTRACEPTION; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; METHODOLOGY; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK; SEXUAL INTERCOURSE; SQUAMOUS EPITHELIUM; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0034924013     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/152460901300233911     Document Type: Article

References (51)

1. Oral contraceptives and neoplasia: An introduction
2. A review of problems of bias and confounding in epidemiologic studies of cervical neoplasia and oral contraceptive use
3. Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association?
4. HPV and cervical neoplasia: Review of case-control and cohort studies
5. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain
6. Human papillomavirus infection and cervical cancer in Latin America
7. Human papillomavirus and invasive cervical cancer in Brazil
8. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: A case-control study in Spain and Colombia
9. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
10. Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico
11. Human papillomaviruses and cervical neoplasia in South Carolina
12. Human papillomavirus-The most significant risk determinant of cervical intraepithelial neoplasia
13. Risk of cervical dysplasia in users of oral contraceptives, intrauterine devices or depot-medroxyprogesterone acetate
14. Oral contraceptive use and cervical intraepithelial neoplasia
15. Oral contraceptive use and the incidence of cervical intraepithelial neoplasia
16. Determinants of squamous intraepithelial lesions (SIL) on Pap smear: The role of HPV infection and of HIV-1-induced immunosuppression
17. Oral contraceptives and cervical cancer-Further findings from the Oxford Family Planning Association contraceptive study
18. Risk factors for cervical intraepithelial neoplasia: Differences between low- and high-grade lesions
19. The role of HPV in the etiology of cervical cancer
20. Case-control study of risk factors for cervical intraepithelial neoplasia in young women
21. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ
22. Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use
23. Risk factors for cervical neoplasia in Denmark
24. Combined oral contraceptives and risk of cervical carcinoma in situ
25. Risk factors for in situ cervical cancer: Results from a case-control study
26. Oral contraceptive use and risk of invasive cervical cancer
27. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study
28. Risk factors for cervical cancer in Colombia and Spain
29. Oral contraceptive use and invasive cervical cancer
30. Determinants of risk of invasive cervical cancer in young women
31. Time since last use of oral contraceptives and risk of invasive cervical cancer
32. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection
33. Oral contraceptive use and malignancies of the genital tract
34. Use of oral contraceptives and risk of invasive cervical cancer in previously screened women
35. Results of a case-control study of the current effect of various factors on cervical cancer risk. 2. Contraceptive behavior and the smoking factor
36. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix
37. Longterm use of oral contraceptives and risk of invasive cervical cancer
38. The safety of oral contraceptives: Epidemiologic insights from the first 30 years
39. Risk factors for cervical intraepithelial neoplasia in Taiwan
40. Barrier methods of contraception and cervical intraepithelial neoplasia
41. The role of contraceptive use in cervical cancer: The Maryland Cervical Cancer Case-Control Study
42. Barrier and spermicidal contraceptive methods and risk of invasive cervical cancer
43. Barrier methods of contraception and the risk of cervical neoplasia
44. Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia
45. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix
46. Injectable contraceptives and risk of invasive cervical cancer: Evidence of an association
47. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer
48. A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, U.K.
49. Cervical cytology associated with levonorgestrel contraception
50. A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms
51. Statistical methods in cancer research. The analysis of case-control studies